Novo Nordisk suffers Wegovy defeat to Viatris in patent court
It is the copy producer Viatris that has challenged three of the patents behind Novo Nordisk’s GLP-1 molecule Semaglutide.
A part of Watch Media
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers
For subscribers